A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)
Status:
Completed
Trial end date:
2007-08-23
Target enrollment:
Participant gender:
Summary
Evaluate the effectiveness of dorzolamide-timolol (Cosopt®) as first line therapy in reducing
intraocular pressure in patients with untreated Open angle glaucoma (OAG) or Ocular
hypertension (OH).